Ferroptosis

Ferroptosis: 질병과의 메커니즘 및 연결

unicircle 2021. 10. 27. 02:23

2021

Ferroptosis: mechanisms and links with diseases

https://www.nature.com/articles/s41392-020-00428-9

 

그림 2: ferroptosis의 신호 전달 경로에 대한 도식적 설명.

 

 

표시된 경로는 지질 ROS 생성을 통해 ferroptosis 감도를 제어합니다. 포스파티딜에탄올아민(PE); 인지질(PL-H); 인지질 알콕실 라디칼(PL-O·); 인지질 퍼옥실 라디칼(PL-OO·); 인지질 하이드로퍼옥사이드(PL-OOH); 트랜스페린(TF). 그림에 사용된 기호에는 생체 분자의 이름이 표시되어 있습니다.

그림 3: 페로프토시스 방지 경로의 개요.

 

 

 

ferroptosis, GSH 의존성 GPx4 경로 및 NADPH 의존성 FSP1 경로에서 확인된 두 가지 방어 메커니즘에 대한 도식적 설명. 글루타민(Gln); 글루타메이트(Glu); 시스테인(Cys); 글리신(Gly); 글루타티온-이황화물 환원효소(GSR); 자극 단백질 1 및 3(SP1/3); 핵인자 Y(NF-Y); cAMP-반응 요소 조절제-타우(CREM-타우); 초기 성장 반응 단백질 1(EGR1); 핵인자 κB(NF-κB); 스테롤 조절 결합 요소 1(SREBP1).

 

Table 1 Summary of ferroptosis inducers.

 

Compound/drug               Target                   Mechanism                                          Model

Erastin System Xc Interfere cystine uptake and deplete GSH, increase LIP level Cell line: HT-1080, SH-SY5Y  
Piperazine erastin System Xc Upregulate PTGS2, suppressed by vitamin E BJeLR cells  
Imidazole ketone erastin System Xc Interfere cystine uptake and deplete GSH Cell line: G-401, DLBCL xenograft model  
Sulfasalazine System Xc Interfere cystine uptake and deplete GSH Nb2 lymphoma cells  
Sorafenib System Xc Blocks system Xc− and deplete GSH HCC cells  
Glutamate System Xc Interfere cystine uptake and deplete GSH HT-1080 cells  
BSO (buthionine sulfoximine) Glutamate-cysteine ligase Mediate glutathione deficiency Newborn rats  
DPI2   Interfere cystine uptake and deplete GSH BJeLR cells  
Cyst(e)inase Cysteine consumption Deplete L-Cysteine via interfering transsulfuration pathway and/or increasing ROS production PCa cells, FVB/N mice  
BAY 87-2243 Mitochondrial complex I Suppress the activity of Mitochondrial complex I, increase ROS Cell line: H460, G361 and SK-MEL-28  
Artesunate Nrf2− antioxidant response element Downregulate GSH level, upregulate lipid ROS and mediate ferritinophagy Cell line: HNC, LX-2; ICR mice,  
(1S,3R)-RSL3 GPX4 Inhibit the activity of GPX4 via binding selenocysteines at active-site Cell line: BJeLR, HT-1080  
ML162, ML210, DPI 7, DPI 10, DPI 12, DPI 13, DPI 17, DPI 18, DPI 19 GPX4 Inhibit the activity of GPX4 BJeLR cells  
Altretamine GPX4 Inhibit the activity of GPX4 U-2932 cells  
Withaferin A GPX4 and KEAP1 inactivation Stimulate Nrf2 via binding KEAP1, inhibit GPX4 IMR-32 and SK-N-SH cells  
FIN56 GPX4 and squalene synthase Increase degradation of GPX4, suppress CoQ10 via targeting and stimulating SQS Cell line: BJeLR, HT-1080, PACN1, MEFs  
Statins (fluvastatin, lovastatin, simvastatin) HMGCR Inhibit HMGCR and suppress GPX4 biosynthesis Cell line: HT-1080, HCC4006  
Hemoglobin   Release iron and produce lethal ROS Cell line: OHSCs  
Hemin   Cause high level of HMOX1 and increase intracellular iron Cell line: IMR-32, HT22, primary cortical neurons; Male Swiss albino mice  
FeCl2, (NH4)2Fe(SO4)2   Release iron and produce lethal ROS Cell line: IMR-32, OHSCs  
Non-thermal plasma Ferritin Break ferritin and induce reduction from Fe(III) to Fe(II) Cell line: IMR-90-SV, SAS, Ca9-22  
Salinomycin, ironomycin DMT1, ferritin, GPX4 Decrease expression of GPX4 and ferritin, and inhibit DMT1 by interrupting lysosomal iron translocation Cell line: BCSCs, CSC  
Siramesine + lapatinib Iron transport Increase transferrin and decrease ferroportin Cell line: MDA MB 231, MCF-7, ZR-75, SKBr3, A549, U87  
FINO2 (1,2-dioxolane) Lipid Inactivate GPX4 and lead to Fe(III) oxidation Cell line: IGROV-1, NCI-H322 M, NCI60, BJ-hTERT  
BAY 11-7085 IκBα Increase HO-1 related to redox regulation Cell line: MCF-7, MDA-MB-231, MDA-MB-468, SKBR3  
Trigonelline,brusatol NRF2 Inhibit Nrf2 Cell line: HNC, HNSCC  
Artemisinin derivatives   Induce ROS and mediate oxidative stress CCRF-CEM cells  
CIL41, CIL56, CIL69, CIL70, CIL75, CIL79   Induce ROS(CIL56 mediate ferroptosis at low concentration while necrotic, non-suppressible phenotype at high) Cell line:BJ cells, HT-1080  

Table 2 Summary of ferroptosis inhibitors.

Compound/drug                 Target                     Mechanism                       Model

Vitamin E, α-toc, trolox, tocotrienols LOX Restrain LOX PUFA oxygenation Cell line: PBMCs, Pfal1; Gpx4 KO C57BL/6J mice  
Deuterated polyunsaturated fatty acid Lipid peroxidation Inhibit lipid peroxidation APP/PS1 mice  
Butylated hydroxytoluene, butylated hydroxyanisole Lipid peroxidation Inhibit lipid peroxidation C57BL/6J mice  
Ferrostatins, liproxstatins Lipid peroxidation Inhibit lipid peroxidation Cell line: HEK-29, HT22, HT-1080  
CoQ10, idebenone Lipid peroxidation Target lipid peroxyl radicals Cell line: HT1080, Pfa1, NCI-H460, NCI-H2291, NCI-H1703 and NCI-H446  
XJB-5-131, JP4-039 Lipid peroxidation Nitroxide-based mitochondrial lipid peroxidation mitigators Cell line: HT-1080, BJeLR, and panc-1 cells  
Baicalein LOX Inhibit 12/15-LOX HT22 cells, TBI mice model  
PD-146176 LOX Inhibit 15-LOX-1 HEK-293 cells  
AA-861 LOX Inhibit 5-LOX HEK-293T cells; ALF rat  
Zileuton LOX Inhibit 5-LOX Cell line: LNCaP, K562, HT22  
Deferoxamine, ciclopirox, deferiprone Iron Reduce intracellular iron HT-1080  
Glutamine deprivation, glutaminolysis inhibitor Glutaminolysis Maybe hinder mitochondrial TCA cycle Cell line: HT-1080, MEFs  
Cycloheximide Protein synthesis Inhibit xCT protein synthesis Primary cortical neurons  
β-mercaptoethanol Reducing agent Reduce Cys2 to Cys OT-1 CD8þ T cell  
Dopamine Neurotransmitter Increase the stability of GPX4 Cell line: PANC1, HEY, MEF, HEK293  
Selenium Selenoproteins Enhance the number of selenoproteins Cell line: MEFs, HT-1080  
Vildagliptin, alogliptin, linagliptin Dipeptidyl-peptidase-4 Reduce lipid peroxidation via inhibiting DPP4 TP53-deficient CRC cells  

*************************************************************